表紙
市場調査レポート

多発性嚢胞腎:世界の治験動向

Polycystic Kidney Disease Global Clinical Trials Review, H2, 2015

発行 GlobalData 商品コード 326150
出版日 ページ情報 英文 93 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
多発性嚢胞腎:世界の治験動向 Polycystic Kidney Disease Global Clinical Trials Review, H2, 2015
出版日: 2015年09月10日 ページ情報: 英文 93 Pages
概要

当レポートでは、多発性嚢胞腎に関する臨床研究の最新動向について調査し、地域・進捗状況・フェーズ (相) ・募集状況別の実施件数や、代表的なスポンサー、開発中の治療薬の情報、世界各国の主要企業・機関での進行状況、有望な薬剤の比較といった情報を盛り込んでお届けします。

イントロダクション

  • 多発性嚢胞腎
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要5カ国における治験件数

G7諸国での治験件数:泌尿生殖器系および性ホルモン関連の治験における多発性嚢胞腎の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:泌尿生殖器系および性ホルモン関連の治験における多発性嚢胞腎の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

多発性嚢胞腎治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • 大塚ホールディングス
    • Pfizer Inc.
    • Kadmon Corporation, LLC
    • 第一三共
    • XORTX Pharma Corp.
    • Novartis AG
    • GLG Pharma LLC
  • 代表的な研究機関・病院の治験の概要
    • Radboud University
    • Mayo Clinic
    • Shanghai Changzheng Hospital
    • Mario Negri Institute for Pharmacological Research
    • The National Institute of Diabetes and Digestive and Kidney Diseases
    • 杏林大学
    • Toranomon Hospital
    • Medical University of Vienna
    • Assistance Publique - Hopitaux de Paris
    • Tehran University of Medical Sciences

5つの代表的な治験のプロファイル

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2852CTIDB

GlobalData's clinical trial report, "Polycystic Kidney Disease Global Clinical Trials Review, H2, 2015" provides an overview of Polycystic Kidney Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Polycystic Kidney Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Polycystic Kidney Disease
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Polycystic Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Polycystic Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Polycystic Kidney Disease
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Polycystic Kidney Disease Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Otsuka Holdings Co., Ltd.
      • Clinical Trial Overview of Otsuka Holdings Co., Ltd.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Ipsen S.A.
      • Clinical Trial Overview of Ipsen S.A.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Kadmon Corporation, LLC
      • Clinical Trial Overview of Kadmon Corporation, LLC
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
      • Diablo Clinical Research, Inc.
      • Clinical Trial Overview of Diablo Clinical Research, Inc.
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
      • Boehringer Ingelheim Pharmaceuticals, Inc.
      • Clinical Trial Overview of Boehringer Ingelheim Pharmaceuticals, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Kyorin University
      • Clinical Trial Overview of Kyorin University
      • Federico II University
      • Clinical Trial Overview of Federico II University
      • Mario Negri Institute for Pharmacological Research
      • Clinical Trial Overview of Mario Negri Institute for Pharmacological Research
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • Shanghai Changzheng Hospital
      • Clinical Trial Overview of Shanghai Changzheng Hospital
      • The National Institute of Diabetes and Digestive and Kidney Diseases
      • Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases
      • Toranomon Hospital
      • Clinical Trial Overview of Toranomon Hospital
      • Addenbrooke's Hospital
      • Clinical Trial Overview of Addenbrooke's Hospital
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • Azienda Ospedaliera Ospedale Policlinico Consorziale
      • Clinical Trial Overview of Azienda Ospedaliera Ospedale Policlinico Consorziale
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Polycystic Kidney Disease Therapeutics, Global, Clinical Trials by Region, 2015*
  • Polycystic Kidney Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Polycystic Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Polycystic Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015*
  • Polycystic Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Polycystic Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Polycystic Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015*
  • Polycystic Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Polycystic Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Polycystic Kidney Disease Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Polycystic Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Polycystic Kidney Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Polycystic Kidney Disease Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Polycystic Kidney Disease Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Polycystic Kidney Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Kadmon Corporation, LLC, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Diablo Clinical Research, Inc., 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim Pharmaceuticals, Inc., 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyorin University, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Federico II University, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Mario Negri Institute for Pharmacological Research, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Changzheng Hospital, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Toranomon Hospital, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Addenbrooke's Hospital, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Ospedale Policlinico Consorziale, 2015*

List of Figures

  • Polycystic Kidney Disease Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Polycystic Kidney Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Polycystic Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Polycystic Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015*
  • Polycystic Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Polycystic Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Polycystic Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015*
  • Polycystic Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Polycystic Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Polycystic Kidney Disease Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Polycystic Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Polycystic Kidney Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Polycystic Kidney Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top